Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$176.20
-0.36-0.20%
al cierre: -
$176.20
0.000.00%
After hour: 4:35 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
iRhythm Technologies Inc ha un obiettivo di prezzo di consenso pari a $171.64, stabilito in base alle ultime valutazioni degli analisti di 14. Le ultime 3 valutazioni degli analisti sono state rilasciate da Baird, Citigroup y Evercore ISI Group il octubre 10, 2025, octubre 7, 2025 y octubre 7, 2025. Con un obiettivo di prezzo medio di $200 tra le Baird, Citigroup y Evercore ISI Group, c'è un implicito 13.51% upside per iRhythm Technologies Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Baird
Citigroup
Evercore ISI Group
Goldman Sachs
Canaccord Genuity
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para iRhythm Technologies
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/10/2025 | 24.86% | Baird | $180 → $220 | Maintains | Outperform | |||
10/07/2025 | 16.35% | Citigroup | $183 → $205 | Maintains | Buy | |||
10/07/2025 | -0.68% | Evercore ISI Group | $185 → $175 | Maintains | In-Line | |||
10/01/2025 | 2.16% | Goldman Sachs | $158 → $180 | Maintains | Neutral | |||
09/29/2025 | 9.53% | Canaccord Genuity | $170 → $193 | Maintains | Buy | |||
09/23/2025 | 4.99% | Evercore ISI Group | → $185 | Initiates | → In-Line | |||
08/28/2025 | 9.53% | Needham | $180 → $193 | Maintains | Buy | |||
08/21/2025 | 3.86% | Citigroup | $167 → $183 | Maintains | Buy | |||
08/20/2025 | 13.51% | B of A Securities | → $200 | Initiates | → Buy | |||
08/01/2025 | 7.83% | JP Morgan | $145 → $190 | Maintains | Overweight | |||
08/01/2025 | -3.52% | Canaccord Genuity | $139 → $170 | Maintains | Buy | |||
08/01/2025 | 2.16% | Wells Fargo | $130 → $180 | Maintains | Overweight | |||
08/01/2025 | 2.16% | Needham | $151 → $180 | Maintains | Buy | |||
07/15/2025 | -16.57% | Morgan Stanley | $160 → $147 | Maintains | Overweight | |||
06/11/2025 | -9.19% | Morgan Stanley | $130 → $160 | Maintains | Overweight | |||
05/22/2025 | -5.22% | Citigroup | $130 → $167 | Maintains | Buy | |||
05/02/2025 | -21.11% | Canaccord Genuity | $152 → $139 | Maintains | Buy | |||
05/02/2025 | -26.22% | Wells Fargo | $104 → $130 | Upgrade | Equal-Weight → Overweight | |||
05/02/2025 | -14.87% | Baird | $133 → $150 | Maintains | Outperform | |||
05/02/2025 | -14.3% | Needham | $138 → $151 | Maintains | Buy | |||
02/24/2025 | -29.63% | Goldman Sachs | $91 → $124 | Maintains | Neutral | |||
02/21/2025 | -26.22% | Citigroup | $100 → $130 | Maintains | Buy | |||
02/21/2025 | -17.71% | Truist Securities | $111 → $145 | Maintains | Buy | |||
02/21/2025 | -40.98% | Wells Fargo | $86 → $104 | Maintains | Equal-Weight | |||
02/21/2025 | -21.68% | Needham | $125 → $138 | Maintains | Buy | |||
01/17/2025 | -29.06% | Needham | $112 → $125 | Maintains | Buy | |||
01/13/2025 | -36.44% | Needham | $96 → $112 | Maintains | Buy | |||
01/08/2025 | -31.9% | Oppenheimer | $105 → $120 | Maintains | Outperform | |||
12/18/2024 | -37% | Truist Securities | $85 → $111 | Maintains | Buy | |||
12/09/2024 | -13.73% | Canaccord Genuity | $125 → $152 | Maintains | Buy | |||
12/03/2024 | -51.19% | Wells Fargo | → $86 | Reinstates | → Equal-Weight | |||
11/01/2024 | -55.16% | Baird | $100 → $79 | Maintains | Outperform | |||
10/31/2024 | -40.41% | Oppenheimer | $145 → $105 | Maintains | Outperform | |||
10/31/2024 | -45.52% | Needham | $119 → $96 | Maintains | Buy | |||
10/22/2024 | -46.08% | Truist Securities | $80 → $95 | Maintains | Buy | |||
10/14/2024 | -54.6% | Truist Securities | $117 → $80 | Maintains | Buy | |||
10/04/2024 | -55.73% | Goldman Sachs | → $78 | Initiates | → Neutral | |||
09/25/2024 | -22.25% | Canaccord Genuity | $122 → $137 | Maintains | Buy | |||
08/22/2024 | -37.57% | Citigroup | $135 → $110 | Maintains | Buy | |||
08/02/2024 | -43.25% | JP Morgan | $133 → $100 | Maintains | Overweight | |||
08/02/2024 | -17.71% | Oppenheimer | $165 → $145 | Maintains | Outperform | |||
08/02/2024 | -37.57% | Baird | $120 → $110 | Maintains | Outperform | |||
08/02/2024 | -33.6% | Truist Securities | $134 → $117 | Reiterates | Buy → Buy | |||
08/02/2024 | -32.46% | Needham | $138 → $119 | Maintains | Buy | |||
07/16/2024 | -23.95% | Truist Securities | $145 → $134 | Maintains | Buy | |||
07/15/2024 | -26.22% | Morgan Stanley | $135 → $130 | Maintains | Overweight | |||
06/20/2024 | -34.73% | Wolfe Research | → $115 | Upgrade | Peer Perform → Outperform | |||
05/03/2024 | -30.76% | Canaccord Genuity | $133 → $122 | Maintains | Buy | |||
05/03/2024 | -21.68% | Needham | $137 → $138 | Maintains | Buy | |||
02/23/2024 | -24.52% | JP Morgan | $142 → $133 | Maintains | Overweight | |||
02/23/2024 | -24.52% | Canaccord Genuity | $121 → $133 | Maintains | Buy | |||
02/23/2024 | -22.25% | Needham | $136 → $137 | Maintains | Buy | |||
01/08/2024 | -22.81% | Needham | $108 → $136 | Maintains | Buy | |||
12/22/2023 | -24.52% | Truist Securities | $115 → $133 | Maintains | Buy | |||
12/12/2023 | -34.73% | Truist Securities | $100 → $115 | Maintains | Buy | |||
12/11/2023 | -37.57% | Citigroup | → $110 | Upgrade | Neutral → Buy | |||
11/03/2023 | -38.71% | Needham | $140 → $108 | Maintains | Buy | |||
10/11/2023 | -23.38% | Morgan Stanley | $149 → $135 | Maintains | Overweight | |||
08/28/2023 | -34.17% | Canaccord Genuity | $136 → $116 | Maintains | Buy | |||
08/07/2023 | -21.68% | Truist Securities | $155 → $138 | Maintains | Buy | |||
08/04/2023 | -15.44% | Morgan Stanley | $149 → $149 | Reiterates | Overweight → Overweight | |||
08/04/2023 | -26.22% | Needham | $151 → $130 | Maintains | Buy | |||
07/19/2023 | -26.22% | Baird | → $130 | Initiates | → Outperform | |||
07/11/2023 | -15.44% | Morgan Stanley | $149 → $149 | Reiterates | Overweight → Overweight | |||
06/08/2023 | -20.54% | BTIG | $165 → $140 | Maintains | Buy | |||
06/07/2023 | -29.06% | Oppenheimer | $166 → $125 | Maintains | Outperform | |||
06/07/2023 | -13.17% | Canaccord Genuity | → $153 | Reiterates | Buy → Buy | |||
06/07/2023 | -34.73% | Citigroup | $135 → $115 | Maintains | Neutral | |||
05/05/2023 | -15.44% | Morgan Stanley | $130 → $149 | Maintains | Overweight | |||
05/05/2023 | -12.03% | Truist Securities | $154 → $155 | Maintains | Buy | |||
05/05/2023 | -23.38% | Citigroup | $130 → $135 | Maintains | Neutral | |||
05/05/2023 | -14.3% | Needham | $133 → $151 | Maintains | Buy | |||
04/17/2023 | -12.6% | Truist Securities | $137 → $154 | Maintains | Buy | |||
04/17/2023 | -3.52% | BTIG | $168 → $170 | Maintains | Buy | |||
04/03/2023 | -26.22% | Citigroup | $110 → $130 | Maintains | Neutral | |||
02/24/2023 | -18.84% | Canaccord Genuity | $135 → $143 | Maintains | Buy | |||
02/24/2023 | -26.22% | Morgan Stanley | $128 → $130 | Maintains | Overweight | |||
02/24/2023 | -24.52% | Needham | $140 → $133 | Maintains | Buy | |||
02/07/2023 | -14.87% | Wells Fargo | → $150 | Initiates | → Overweight | |||
01/06/2023 | -27.36% | Morgan Stanley | $165 → $128 | Maintains | Overweight | |||
12/20/2022 | -13.17% | Truist Securities | $167 → $153 | Maintains | Buy | |||
12/12/2022 | -37.57% | Citigroup | $144 → $110 | Maintains | Neutral | |||
11/02/2022 | -18.27% | Citigroup | $147 → $144 | Maintains | Neutral | |||
11/02/2022 | -20.54% | Needham | $185 → $140 | Maintains | Buy | |||
10/17/2022 | -5.22% | Truist Securities | $185 → $167 | Maintains | Buy | |||
10/11/2022 | -6.36% | Morgan Stanley | $172 → $165 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de iRhythm Technologies (IRTC)?
El último precio objetivo de iRhythm Technologies (NASDAQ:IRTC) fue comunicado por Baird el octubre 10, 2025. La firma de analistas fijó un precio objetivo para $220.00 que espera IRTC a rise dentro de 12 meses (un posible 24.86% upside). 36 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre iRhythm Technologies (IRTC)?
La última calificación de analistas para iRhythm Technologies (NASDAQ:IRTC) fue proporcionada por Baird, y iRhythm Technologies mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de iRhythm Technologies (IRTC)?
La última revisión al alza de iRhythm Technologies Inc se produjo en mayo 2, 2025, cuando Wells Fargo elevó su precio objetivo a $130. Wells Fargo anteriormente tenía an equal-weight para iRhythm Technologies Inc.
¿Cuándo fue la última revisión a la baja de iRhythm Technologies (IRTC)?
No hay una última revisión a la baja para iRhythm Technologies.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para iRhythm Technologies (IRTC)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de iRhythm Technologies, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de iRhythm Technologies se registró el octubre 10, 2025, por lo que la próxima calificación estará disponible en torno al octubre 10, 2026.
¿Es correcta la calificación de los analistas sobre iRhythm Technologies (IRTC)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de iRhythm Technologies (IRTC) fue un mantuvo con un precio objetivo de $180.00 a $220.00. El precio actual al que cotiza iRhythm Technologies (IRTC) es de $176.20, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.